Clinical trial
An Observational Study of Natural Disease Progression in Participants With Macular Dystrophies Expressing a Stargardt-type Clinical Presentation
NCT07425574 is registered in ClinicalTrials.gov with Astellas Pharma Global Development, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Natural Disease Progression in Participants With Macular Dystrophies Expressing a Stargardt-type Clinical Presentation
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 20, 2026
- Completion date
- July 31, 2028
- Enrollment
- 90 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
stargardt disease, stargardt macular dystrophy, stargardt-like macular dystrophy